Wen L M, Lü G D, Zhao J, Lu S, Gao H J, Chen B, Ma Y F, Xiao Y F, Yuan Y, Zhang H B, Liu H, Wang J H
Department of Clinical Pharmacy, First Affiliated Hospital of Xinjiang Medical University, No. 137 Liyushan South Road, Urumqi 830054, Xinjiang, China.
J Parasitol. 2017 Dec;103(6):699-707. doi: 10.1645/16-164. Epub 2017 Sep 13.
Ribosomal protein S9 (RPS9) is an essential functional gene that participates in DNA repair and developmental regulations. A sequence homolog of RPS9 has been found to be upregulated in the protoscoleces (PSCs) of Echinococcus granulosus treated with artemisinin. However, E. granulosus RPS9 (EgRPS9) has not been identified before. In the present study, the 657-base pair (bp) cDNA encoding EgRPS9 was cloned. Amino acid sequence analysis showed that EgRPS9 was similar to the RSP9 proteins from Schistosoma japonicum (SjRPS9, 86%) and Schistosoma mansoni (SmRPS9, 79%). Phylogenetic tree analysis showed that EgRPS9, SmRPS9, and SjRPS9 were clustered together. We detected the EgRPS9 gene and protein expression in PSCs exposed to artesunate (AS) which displayed a dose-dependent reduction in PSC viability for 24 hr. The results showed that the EgRPS9 ratio of the 10-μM AS-treated ( P < 0.01) and 40-μM AS-treated ( P < 0.05) groups were increased from that of the control group. In addition, the level of reactive oxygen species (ROS) in the AS-treated groups increased in a dose-dependent manner compared to the level in the control group. In conclusion, the expression of EgRPS9 could be induced by ROS and might participate in the oxidative damage-based anti-parasite mechanism of AS treatment.
核糖体蛋白S9(RPS9)是一个参与DNA修复和发育调控的必需功能基因。已发现RPS9的一个序列同源物在用青蒿素处理的细粒棘球绦虫原头蚴(PSC)中上调。然而,之前尚未鉴定出细粒棘球绦虫RPS9(EgRPS9)。在本研究中,克隆了编码EgRPS9的657个碱基对(bp)的cDNA。氨基酸序列分析表明,EgRPS9与日本血吸虫(SjRPS9,86%)和曼氏血吸虫(SmRPS9,79%)的RSP9蛋白相似。系统发育树分析表明,EgRPS9、SmRPS9和SjRPS9聚集在一起。我们检测了暴露于青蒿琥酯(AS)的PSC中EgRPS9基因和蛋白表达,AS在24小时内使PSC活力呈剂量依赖性降低。结果表明,10μM AS处理组(P<0.01)和40μM AS处理组(P<0.05)的EgRPS9比例相对于对照组有所增加。此外,与对照组相比,AS处理组中的活性氧(ROS)水平呈剂量依赖性增加。总之,EgRPS9的表达可由ROS诱导,并可能参与AS治疗基于氧化损伤的抗寄生虫机制。